A Complete Guide to MAT for Women in Recovery

What MAT Actually Is

Medication-Assisted Treatment combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders, primarily opioid use disorder (OUD). For some women, alcohol use disorder is also treated with medications (naltrexone, acamprosate, disulfiram), though the term "MAT" most often refers to opioid treatment.

MAT is not "replacing one drug with another." The medications work fundamentally differently from the drugs that caused the disorder — they stabilize the brain's opioid system, reduce or eliminate cravings, and prevent withdrawal, without producing the euphoric high that drove the original addiction. Decades of research show MAT reduces overdose mortality, increases treatment retention, and supports better long-term recovery outcomes than abstinence-only approaches for opioid use disorder.

The Three Main Medications

Methadone

A long-acting opioid agonist, fully activating the opioid receptors but in a stable, controlled way. Taken once daily, typically at a federally regulated methadone clinic (Opioid Treatment Program or OTP). Effective for severe opioid use disorder, particularly when other medications haven't worked. Strict regulations around dispensing — for many women, the daily clinic visit is both stabilizing structure and a logistical burden.

Common Methadone FAQs:

• Is methadone addictive? Physically, yes — stopping abruptly causes withdrawal. But "addictive" in the colloquial sense (out-of-control use causing harm) doesn't apply when taken as prescribed in a clinical program.
• How long do people stay on methadone? Variable. Some women stay for months, some for years, some indefinitely. The right duration is clinical, not moral.
• Can I taper off methadone? Yes, gradually and under medical supervision. The taper is slow, often over months.
• Can I use methadone during pregnancy? Yes — methadone is one of the standards of care for pregnant women with opioid use disorder. Untreated OUD in pregnancy carries far higher risks than MAT.

Buprenorphine (Suboxone, Subutex, Sublocade)

A partial opioid agonist — activates the receptors enough to reduce craving and withdrawal, but with a "ceiling effect" that limits its abuse potential and respiratory depression risk. Comes in several forms:

• Suboxone (buprenorphine + naloxone) — sublingual film or tablet; the naloxone prevents misuse via injection. Most common form for ongoing maintenance.
• Subutex (buprenorphine alone) — sublingual tablet; used during pregnancy (naloxone isn't recommended in pregnancy) and in early induction.
• Sublocade — monthly injectable form of buprenorphine; for women established on oral buprenorphine who prefer not to take daily medication.

Buprenorphine can be prescribed by trained physicians (and increasingly nurse practitioners and PAs) in regular medical offices, removing the daily-clinic burden of methadone. This makes it the most common MAT option for women whose use is in the moderate range.

Subutex vs Suboxone — the difference:

Same active ingredient (buprenorphine); Suboxone adds naloxone. The naloxone is inactive when taken sublingually as directed; it only becomes active if the medication is misused (injected). So Suboxone has an abuse-prevention safeguard that Subutex doesn't. Subutex is used when naloxone isn't appropriate (pregnancy, naloxone sensitivity, induction phase).

Naltrexone (Vivitrol)

An opioid antagonist — blocks the opioid receptors rather than activating them. Taken as a daily pill (Revia) or monthly injection (Vivitrol). Doesn't cause physical dependence. Best suited for women who have completed detox and want to prevent return to opioid use, or for women whose primary issue is alcohol use disorder (naltrexone is FDA-approved for both).

Naltrexone requires being opioid-free for 7-10 days before starting; otherwise precipitates immediate withdrawal. This is a meaningful constraint — many women in early opioid recovery can't tolerate the pre-treatment abstinence window, which is why buprenorphine is often the preferred starting medication.

MAT and Women — Specifics Worth Knowing

• Hormonal cycles can affect medication metabolism — dosing may need adjustment across the menstrual cycle
• Women metabolize methadone somewhat differently than men, often resulting in lower blood concentrations at the same dose
• Pregnancy and breastfeeding considerations are well-established — methadone and buprenorphine are both compatible with pregnancy under clinical supervision
• Co-occurring conditions (depression, anxiety, PTSD, eating disorders) are more common in women with OUD and need integrated treatment alongside MAT
• Childcare and logistical barriers disproportionately affect women's access to daily-clinic methadone programs
• Stigma — particularly within families, communities of faith, and some recovery communities — falls heavier on women in MAT than on men

How to Talk to Your Family About MAT

This is the part that often sits heaviest. Even when the medical decision is clear, the family conversation can be hard. Common challenges and approaches:

"Aren't you just replacing one drug with another?"

This is the most common pushback, often coming from family members who have been hurt by the addiction and want clean abstinence. The honest answer: MAT medications are clinically distinct from the drugs they treat. They're prescribed at stable doses, they don't produce a high, and the research is unambiguous that they reduce overdose mortality and improve recovery outcomes for opioid use disorder. Comparing them to active addiction is medically inaccurate, even when the comparison feels intuitive.

"How long will you be on it?"

Honest answer: "As long as my clinical team and I think it's the right tool." For some women that's months; for others, years; for some, indefinitely. The duration is clinical, not moral. Insulin for diabetes is also taken indefinitely; nobody asks diabetics how long they'll "need to be on insulin." The frame around chronic medical conditions applies here.

"Are you really in recovery if you're on a medication?"

Yes. Recovery is the absence of compulsive use, the rebuilding of life, the integration of self — not the absence of any medication. Some 12-step communities have evolved on this; others haven't. If your family or community is rigid on this point, you may need to find recovery spaces that aren't (SMART Recovery, MAT-friendly NA groups, women's recovery circles, professional therapy).

Practical Tips for the Conversation

• Choose a calm, private moment — not in the middle of a crisis or after recent conflict
• Lead with what you want them to understand, not with defense
• Bring information they can read on their own (this article, or your prescriber's printed materials)
• Acknowledge their fears — they've been hurt or scared too
• Don't try to convince them of everything at once; the conversation is the beginning, not the resolution
• If they remain unsupportive, that's information about who can be part of this season of your recovery

How Anchored Tides Approaches MAT

ATR doesn't provide MAT directly — we coordinate with prescribers and MAT programs to support women whose recovery includes medication-assisted treatment.

• Coordination with MAT prescribers — for women already on methadone, buprenorphine, or naltrexone
• Referral pathways — for women considering MAT, we can connect with trusted prescribers
• Integrated therapy — CBT, DBT, EMDR alongside MAT medications creates the most effective recovery foundation
• Three outpatient levels of care (PHP, IOP, OP) — flexible enough for women in MAT programs
• Dual-Diagnosis / Co-Occurring Disorders treatment for the conditions that often co-occur with OUD
• Mental Health track for women whose primary need is mental health
• Family programming — support for partners, parents, adult children navigating the MAT conversation alongside their loved one
• In-network with HMOs, EPOs, and PPOs across Blue Shield, BCBS, Anthem, Highmark, Regence, Premera, Multiplan, and Horizon

Take the Next Step

If you're considering MAT, already on MAT and looking for therapy support, or navigating the family conversation around it, we can help. Our team works with women across the MAT spectrum and coordinates closely with prescribers.

Call (866) 329-6639 or Verify Your Insurance — confidential, no obligation.